Pitcairn CO Abb Vie Inc. Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Pitcairn CO holds 36,272 shares of ABBV stock, worth $6.37 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

36,272

Previous 38,554 5.92%

Holding current value

$6.37 Million

Previous $6.61 Million 8.32%

% of portfolio

0.43%

Previous 0.41%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $373,882 - $454,871	-2,282 Reduced 5.92%	36,272 $7.16 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $298,125 - $348,143	1,926 Added 5.26%	38,554 $6.61 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $149,112 - $169,899	-933 Reduced 2.48%	36,628 $6.67 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $145,580 - $163,958	1,058 Added 2.9%	37,561 $5.82 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $1.22 Million - $1.41 Million	9,147 Added 33.44%	36,503 $5.44 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $404,288 - $503,109	-3,051 Reduced 10.03%	27,356 $3.69 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $114,531 - $131,899	792 Added 2.67%	30,407 $4.85 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $135,958 - $163,050	983 Added 3.43%	29,615 $4.79 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $39,189 - $44,947	292 Added 1.03%	28,632 $3.84 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $191,154 - $243,019	1,389 Added 5.15%	28,340 $4.34 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $122,345 - $151,796	-927 Reduced 3.33%	26,951 $4.37 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $6,338 - $8,019	-59 Reduced 0.21%	27,878 $3.78 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $67,244 - $76,332	632 Added 2.31%	27,937 $3.01 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $62,599 - $69,739	-595 Reduced 2.13%	27,305 $3.08 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $109,154 - $120,165	1,067 Added 3.98%	27,900 $3.02 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $78,236 - $105,627	-972 Reduced 3.5%	26,833 $2.88 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $467,608 - $548,817	-5,443 Reduced 16.37%	27,805 $2.44 Million
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $326,716 - $437,195	4,453 Added 15.46%	33,248 $3.27 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $167,700 - $254,254	-2,600 Reduced 8.28%	28,795 $2.19 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $220,212 - $275,533	-3,053 Reduced 8.86%	31,395 $2.78 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $33,190 - $39,904	527 Added 1.55%	34,448 $2.61 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $638,472 - $816,117	9,718 Added 40.15%	33,921 $2.47 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $272,458 - $320,670	3,532 Added 17.09%	24,203 $1.95 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $134,524 - $165,905	1,728 Added 9.12%	20,671 $1.91 Million
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $440,460 - $489,653	-4,954 Reduced 20.73%	18,943 $1.79 Million
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $11,761 - $13,916	-131 Reduced 0.55%	23,897 $2.21 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $40,760 - $54,582	443 Added 1.88%	24,028 $2.28 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $523,836 - $574,430	5,849 Added 32.98%	23,585 $2.28 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $1.24 Million - $1.58 Million	17,736	17,736 $1.58 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account